The conditions vary, but those with IRDs may face many similar challenges, including night blindness (nyctalopia), declining vision, or blindness at birth.
Thanks to renewed focus, retinal gene therapy research is showing exciting potential. Meet some of the field’s pioneering researchers and get a primer on the science.
Science can now decipher which gene is responsible for causing a number of IRDs. Here’s a simple overview to help you understand the basics of the genetic testing process.
Introducing a new genetic testing initiative from Spark Therapeutics! Visit IDYOURIRD.com to see if you may be eligible.
Sofia, 13, believes that success rests in the power of perseverance—and elegant pliés, of course. Leber congenital amaurosis (LCA) may be limiting her vision, but it isn’t stopping this young ballerina from pursuing what she loves. Watch video
We are constantly connecting with folks in the IRD community to bring new stories to aSharedVision. Check out the latest additions.
At Spark, we are continually talking to patients and their families to understand the needs of the IRD community. You told us you wanted help with genetic testing, and here’s what happened next. Read story
Two moms—one who has retinitis pigmentosa (RP), and one who is raising a daughter with a form of Leber congenital amaurosis (LCA due to mutations in the IQCB1 gene)—talk about the importance of genetic testing. Watch video